Delivery Order SPE2DB22D3010-SPE2DB25FP3DM
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) valued at $29,155.74 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was executed on August 22, 2025, with an ultimate completion date of August 25, 2025. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $34,557.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-competitive, non-set-aside delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under a larger vehicle, leveraging AmerisourceBergen's established position as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $10,858.62. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $6,416.84 under a firm fixed-price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award utilizing the contractor's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $28.6K to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 14, 2025, with completion targeted for July 15, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement, leveraging the company's existing indefinite delivery...
- The Defense Logistics Agency awarded a $39,787.21 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply delivery under AmerisourceBergen's broader relationship with the...
- The Defense Logistics Agency awarded a $3,111.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, non-set-aside delivery order represents a discrete purchase under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for RINVOQ ER 15 mg tablets (30-count units) valued at $3,125.66. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing contract vehicle. The order is scheduled for completion by July 16, 2025, with performance at the company's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,265.94 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $13,070.59 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitive award utilizes firm fixed pricing with a completion date of June 16, 2025, and carries no set-aside designation. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...